Ann: Prospectus, page-36

NZ, the marketing mistakes started from the beginning when they over-hyped the drug based only on the lab results before the first clinical trials creating suspicion. This has left a dark cloud over PAA for no good reason and has forced it to raise capital at discounted sp, which feeds investors worries, along with the long waits with very little news,, In old tabloid lingo MPL or PPL-1 would be called a "miracle" drug that successfully treats currently untreatable late stage cancers. Let's hope that a strategic marketing campaign like you suggested gets that message across to the public beginning when the first results start of these trials start coming in. I'm bitter, but I am holding on. I have no doubts about the quality of the people on the technical side or their sincerity.
N